(4S)-4-(3-"F-fluoropropyl) L-Glutamate (FSPG), "F-fluoroestradiol (FES), and "Fflurodeoxyglucose (FDG) PET/CT in Phenotyping Patientswith Hormone Refractory Breast Cancer

被引:0
|
作者
Cheng, Mei-Fang [1 ,2 ]
Chen Wei-Wu [2 ,3 ]
Huang, Ya-Yao [1 ,2 ]
Tien, Yu-Wen [2 ,4 ]
Liu, Chia-Ju [5 ]
Lu, Yen-Shen [2 ,3 ]
Yen, Rouh-Fang [1 ,2 ]
机构
[1] Natl Taiwan Univ Hosp, Nucl Med, Taipei, Taiwan
[2] Natl Taiwan Univ, Coll Med, Taipei, Taiwan
[3] Natl Taiwan Univ Hosp, Oncol, Taipei, Taiwan
[4] Natl Taiwan Univ Hosp, Surg, Taipei, Taiwan
[5] Natl Taiwan Univ Hosp, Yunlin Branch, Nucl Med, Touliu, Yunlin, Taiwan
关键词
D O I
暂无
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
205
引用
收藏
页数:1
相关论文
共 21 条
  • [21] Assessment of Tumor Redox Status through (S)-4-(3-[18F] fluoropropyl)-L-Glutamic Acid PET Imaging of System xc- Activity
    McCormick, Patrick N.
    Greenwood, Hannah E.
    Glaser, Matthias
    Maddocks, Oliver D. K.
    Gendron, Thibault
    Sander, Kerstin
    Gowrishankar, Gayatri
    Hoehne, Aileen
    Zhang, Tong
    Shuhendler, Adam J.
    Lewis, David Y.
    Berndt, Mathias
    Koglin, Norman
    Lythgoe, Mark F.
    Gambhir, Sanjiv S.
    Arstad, Erik
    Witney, Timothy H.
    CANCER RESEARCH, 2019, 79 (04) : 853 - 863